Bogunia-Kubik Katarzyna, Łacina Piotr
Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Laboratory of Tissue Immunology, Medical Centre, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Br J Haematol. 2017 Sep;178(5):661-675. doi: 10.1111/bjh.14704. Epub 2017 Apr 26.
Graft-versus-host disease (GvHD) is a serious complication affecting the recipients of allogeneic haematopoietic stem cells. In this present review we attempt to summarize the current knowledge on the effect of the donor and recipient genotypes on GvHD, starting from human leucocyte antigen (HLA) matching for an optimal donor selection, typing of non-classical HLA and minor histocompatibility antigens through the polymorphic variations in genes coding for non-HLA proteins contributing to the development of GvHD and response to treatment. The results of recent Candidate Gene Studies (CGS) and Genome-Wide Association Studies (GWAS) are presented and discussed.
移植物抗宿主病(GvHD)是影响异基因造血干细胞接受者的一种严重并发症。在本综述中,我们试图总结目前关于供体和受体基因型对移植物抗宿主病影响的知识,从用于最佳供体选择的人类白细胞抗原(HLA)匹配开始,到非经典HLA和次要组织相容性抗原的分型,再到编码非HLA蛋白的基因中的多态性变异,这些变异有助于移植物抗宿主病的发展及对治疗的反应。文中呈现并讨论了近期候选基因研究(CGS)和全基因组关联研究(GWAS)的结果。